guidelines

Polymyxins are often the only agents that remain in vitro active against extensively resistant bacterial pathogens. However, the use of polymyxins is compromised by the number of unresolved issues, including the technical aspects of antimicrobial …

An update on 2010 clinical practice guideline on Clostridium difficile infection (CDI) by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA) was published in March 2018. This new version of …

The article analyzes contemporary recommendations for diagnosis and treatment of acute tonsillopharyngitis, and essential practical aspects for management of patients with this infection considering characteristics of antibiotic resistance profile of …

Diabetic foot infections (DFIs) are a frequent clinical problem. Properly managed, most of them can be cured, but many patients needlessly undergo amputations because of improper diagnostic and therapeutic approaches. Foot infection should be defined …

Previous edition of the joint guidelines of the European Respiratory Society and European Society of Clinical Microbiology and Infectious Disease on the management of lower respiratory tract infections in adult patients was published in 2005 and …

Severe pneumonia is associated with high mortality rates, and appropriate severity assessment plays a main role in timely admission to the hospital, including intensive care unit. There are several scores for risk (poor outcome) assessment in …

In this review currently available data on the etiological diagnosis, management and treatment of encephalitis are discussed in accordance with the principles of evidence-based medicine. The article represents data in this research field, including …

Legionella spp. is an uncommon but important causative pathogen of respiratory tract infections occurring both sporadically and in epidemics. An interest in it has emerged recently after outbreak of legionellosis in Sverdlovsk region. In this …

Community-acquired pneumonia (CAP) is the 4-8th leading killer of people worldwide and the most leading cause of death from infections in US. This article is a review of innovations and differences between the recent American Thoracic Society (ATS) …

Tumor necrosis factor (TNF)-blocking agents are one of the new option in the treatment of immune-mediated inflammatory diseases, such as rheumatoid arthritis, Crohn disease, ulcerative colitis. However, anti-TNF therapy is associated with the …